Weekly 70 mg/m2 Carfilzomib for Multiple Myeloma Patients Refractory to 27 mg/m2 Carfilzomib
Clinical trial NCT02294357 · TERMINATED
Trial details
- NCT number
- NCT02294357
- Sponsor
- Oncotherapeutics
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-12-01
- Primary completion
- 2020-09-21
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.